Illumina
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.
Illumina Company Profile
President & CEO: Francis deSouza
CEO photo:
Website: www.illumina.com
Ticker symbol: ILMN
Headquarters: San Diego, CA
Illumina employees: 5,500+ globally
Revenues: $2.4 Billion USD in 2016
Founded: 1998
Founders: Larry Bock, Anthony Czarnik, David Walt, Mark Chee, John Stuelpnagel
Illumina News
SEC Investigating Illumina Over Grail Acquisition
Illumina said the SEC has requested documents, including records "related to the conduct and compensation of certain members of Illumina and Grail management."
Guardant Health, Illumina Settle Patent Suit, Renew Long-Term Commercial Partnership
The companies have agreed to jointly request that the litigation between them be dismissed with prejudice and have renewed their purchase and supply commitment.
In Brief This Week: Labcorp, Enzo; Revvity; Becton Dickinson; Yourgene, Illumina; More
News items for the week of July 24, 2023.
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Top Five Articles on 360Dx Last Week: FDA Clearances; Labcorp Acquisition, Management Deal; and More
Last week, readers were most interested in a story about new 510(k) clearances from the FDA for June.